41177-35-9
中文名称
N-[[4-[2-[[(2,3-Dihydrobenzofuran-7-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-N'-cyclohexylurea
英文名称
N-[[4-[2-[[(2,3-Dihydrobenzofuran-7-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-N'-cyclohexylurea
CAS
41177-35-9
分子式
C24H29N3O5S
分子量
471.57
MOL 文件
41177-35-9.mol
结构式
![41177-35-9 结构式](https://www.chemicalbook.com/CAS/GIF/41177-35-9.gif)
基本信息
中文别名
化合物 T15013
英文别名
CS-476
NSC302998
N-[[4-[2-[[(2,3-Dihydrobenzofuran-7-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-N'-cyclohexylurea
7-Benzofurancarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2,3-dihydro-
NSC302998
N-[[4-[2-[[(2,3-Dihydrobenzofuran-7-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-N'-cyclohexylurea
7-Benzofurancarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2,3-dihydro-
物理化学性质
储存条件 | -20°C储存 |
溶解度 | 溶于二甲基亚砜 |
常见问题列表
生物活性
CS476 是一种有效的降血糖试剂。
体内研究
In normal fasting dogs, rabbits, rats and mice the maximal hypoglycaemia produced by intravenous administration of CS476 is comparable on a weight basis to that produced by Glibenclamide. Randomized Latin square experiments in dogs show that 0.03 mg/kg orally of CS476 and of Glibenclamide cause the same maximal decrease of blood glucose and that CS476 has the shorter duration of action. CS476 has no hypoglycaemic effect in totally pancreatectomized dogs nor in streptozotocin diabetic dogs and rats. The insulin releasing activity is studied in dogs after intravenous and oral administration of equipotent doses of CS476, Tolbutamide and Glibenclamide.
供应商信息 更多
TargetMol中国(陶术生物)
联系电话:
4008200310
产品介绍:
中文名称:化合物 T15013
英文名称:CS476;CS476,CS-476
CAS:41177-35-9
纯度:98%
包装信息:5 mg